Login / Signup
Yu Xia
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Pi K Akt
Poor Prognosis
Toll Like Receptor
Dna Repair
Top Venues
Journal of oncology
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Si-Yuan Wang
,
Yu Xia
,
Pu Huang
,
Cheng Xu
,
Yiyu Qian
,
Tian Fang
,
Qing-Lei Gao
Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor.
Journal of oncology
2023 (2023)
Ping Jin
,
Xin Li
,
Yu Xia
,
Hua-Yi Li
,
Xiaoting Li
,
Zong-Yuan Yang
,
Zhen Wang
,
Cheng Xu
,
Tian Fang
,
Dongchen Zhou
,
Xiaoming Xiong
,
Si-Yuan Wang
,
Sen Xu
,
Qing-Lei Gao
Bepotastine sensitizes ovarian cancer to PARP inhibitors through suppressing NF-κB-triggered SASP in cancer-associated fibroblasts.
Molecular cancer therapeutics
(2023)
Si-Yuan Wang
,
Yu Xia
,
Pu Huang
,
Cheng Xu
,
Yiyu Qian
,
Tian Fang
,
Qing-Lei Gao
Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor.
Journal of oncology
2023 (2023)